Table 4 Treatment-related adverse events (TRAEs)
Adverse events | Any grade, n (%) | Grade 3, n (%) |
|---|---|---|
Increased ALT or AST | 16 (36.4%) | 1 (2.3%) |
Diarrhoea | 13 (29.5%) | 3 (6.8%) |
Post-embolization syndrome (PES) | 13 (72.2%) | 0 |
Hand-foot skin reactions | 12 (27.3%) | 1 (2.3%) |
Hypertension | 10 (22.7%) | 2 (4.5%) |
Fatigue | 7 (15.9%) | 1 (2.3%) |
Arthrodynia | 3 (6.8%) | 0 |
Decreased appetite | 3 (6.8%) | 0 |
Hypothyroidism | 3 (6.8%) | 0 |
Oral mucositis | 2 (4.5%) | 0 |
Pruritus | 2 (4.5%) | 0 |
Nausea | 2 (4.5%) | 0 |
Hyperbilirubinemia | 1 (2.3%) | 1 (2.3%) |